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Bioenergetics Consequences of Mitochondrial Transplantation in
Cardiomyocytes
Paria Ali Pour , MS; M. Cristina Kenney , MD, PhD; Arash Kheradvar , MD, PhD
Background-—Mitochondrial transplantation has been recently explored for treatment of very ill cardiac patients. However, little is
known about the intracellular consequences of mitochondrial transplantation. This study aims to assess the bioenergetics
consequences of mitochondrial transplantation into normal cardiomyocytes in the short and long term.
Methods and Results-—We first established the feasibility of autologous, non-autologous, and interspecies mitochondrial
transplantation. Then we quantitated the bioenergetics consequences of non-autologous mitochondrial transplantation into
cardiomyocytes up to 28 days using a Seahorse Extracellular Flux Analyzer. Compared with the control, we observed a statistically
significant improvement in basal respiration and ATP production 2-day post-transplantation, accompanied by an increase in
maximal respiration and spare respiratory capacity, although not statistically significantly. However, these initial improvements
were short-lived and the bioenergetics advantages return to the baseline level in subsequent time points.
Conclusions-—This study, for the first time, shows that transplantation of non-autologous mitochondria from healthy skeletal
muscle cells into normal cardiomyocytes leads to short-term improvement of bioenergetics indicating “supercharged” state.
However, over time these improved effects disappear, which suggests transplantation of mitochondria may have a potential
application in settings where there is an acute stress. ( J Am Heart Assoc. 2020;9:e014501. DOI: 10.1161/JAHA.119.014501.)
Key Words: mitochondria • mitochondrial cardiomyopathy • mitochondrial transplantation • mitochontrial respiratory chain
disease • mitochondrial transfer
T he mitochondrion found in most eukaryotic cells providesnearly all of the cell’s energy by the oxidative phospho-
rylation process through themitochondrial respiratory chain.1,2
The eukaryotes’ mitochondrion is believed to have evolved
from a small, autotrophic bacterium that was engulfed by a
larger primitive, heterotrophic, eukaryotic cell.2 Owing to its
origin, mitochondrion has a (maternally inherited) genome that
is distinct from the cell’s nuclear genome. Although mitochon-
drion was once a free-living organism, through time and
because of its symbiotic relationship, some of its genome has
been translocated to the cell’s nucleus, making it an intracel-
lular organelle dependent on the nucleus. Like the nuclear
genome, mitochondrial DNA is constantly prone to damage and
mutations. However, mitochondria lack effective DNA repair
mechanisms, so the mitochondrial DNA defects often clonally
accumulate in subsequent mitochondria. The majority of
mitochondrial diseases occur as a result of mutations in either
nuclear DNA or mitochondrial DNA. Regardless, the phenotypic
representations of all mitochondrial disorders are deficiencies
in energy metabolism and cell function with cardiac involve-
ment as a common manifestation, ranging from cardiomyopa-
thy to arrhythmias and heart failure.2–4
Recently, much interest has been devoted to cellular
biotherapies involving mitochondria. Elliot et al5 have suc-
cessfully demonstrated that introduction of normal mitochon-
dria into human breast cancer cells restores mitochondrial
function, inhibits cancer cell proliferation, and reverses
chemoresistance by increasing the sensitivity of cells to
breast cancer medication. Moreover, early clinical feasibility
of mitochondrial replacement therapy in humans has provided
hope to mitigating inherited mitochondrial disorders,6 and
transplantation of mitochondria into the ischemic zone of the
myocardium has been shown to improve recovery in cardiac
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ischemia-reperfusion injury.7–17 The mechanism of mitochon-
drial uptake is a question that is actively under investigation,
and some of the suggested mechanisms are actin-dependent
endocytosis17 and macropinocytosis.18 However, little is
known about the intracellular fate of mitochondria during
transplantation and, in particular, the bioenergetics conse-
quences of mitochondrial transplantation. We aimed to
address this question by studying how cellular bioenergetics
are affected in the short and long term after mitochondrial
transplantation. The requirement for institutional review board
approval was waived given that no human studies were
involved.
Methods
All the data that support the findings of this study are
available from the first author upon reasonable request.
Cell Culture and Mitochondrial Isolation
Cells from the H9c2 cell line derived from rat embryonic hearts,
rat skeletal muscle cells from the L6 cell line, and ARPE-19 cells
from human retina were grown per manufacturer’s instructions
(ATCC, Manassas, VA). H9c2 and L6 cells were grown in
complete growth medium, which consisted of DMEM, FBS to a
final concentration of 10%, and penicillin-streptomycin to a final
concentration of 1% (Thermo Fisher Scientific, Waltham, MA).
ARPE-19 cells were grown in DMEM/F-12 (ATCC), FBS to a final
concentration of 10%, and penicillin-streptomycin to a final
concentration of 1% (Thermo Fisher Scientific). To conserve the
myoblastic properties of H9c2 cells, cells were grown at a
seeding density of 1 104 viable cellscm2 and passaged when
approximately 80% confluent (every 3 days).
In our studies, as schematically shown in Figure 1, we
isolated mitochondria from H9c2 cells for autologous trans-
plantation (Figure 2A and 2B) and L6 cells for non-autologous
(Figure 2C) and interspecies transplantation (Figure 2D), using
a commercially available isolation kit for cultured cells (Thermo
Fisher Scientific). Cardiomyocytes were plated at 50K on a l-
slide 8-well ibiTreat slide (ibidi, Martinsried, Germany) the day
before mitochondrial isolation for imaging purposes, 40K cells
onto a Seahorse Cell Culture Microplate (Agilent Technologies,
Santa Clara, CA) the day before running the Seahorse assay,
and 40K cells onto a 96-well plate the day before running the
MitoSOX superoxide production assay. For holotomographic
microscopy (Figure 2C), a 35-mm dish (ibidi) was used.
Mitochondrial Labeling and Imaging
Native mitochondria were labeled with MitoTracker Green FM
with excitation/emission 490/516 nm at 37°C for 45 min-
utes and washed twice with sterile PBS (Thermo Fisher
Scientific). Isolated mitochondria were labeled with pHrodo
Red Succinimidyl Ester with excitation/emission 560/
585 nm for 30 minutes at 4°C, washed twice with sterile
PBS (Thermo Fisher Scientific), and then coincubated with
H9c2 cells. The nucleus was labeled with NucBlue Live with
excitation/emission 360/460 nm (Thermo Fisher Scientific).
A time-lapse microscopy was subsequently conducted with
both fluorescence and phase contrast/DIC channels to
capture the dynamic behavior of mitochondrial internalization
(Figure 2B; Video S1). Images were acquired either using a
wide-field (Olympus IX83; Olympus Corporation, Tokyo, Japan)
or confocal microscope (Zeiss LSM 780; Zeiss Microscopy,
Jena, Germany). The respective data were analyzed using Fiji
(NIH, Bethesda, MD) and IMARIS software (Bitplane AG,
Zurich, Switzerland).
Bioenergetics Assessment After Mitochondrial
Transplantation
To investigate the bioenergetics consequences of mitochondrial
transplantation, oxygen consumption rate (OCR) and extracellu-
lar acidification (ECAR) rate weremeasured post-transplantation
using a Seahorse XF24 Analyzer. First, H9c2 cells were plated at
seeding densities of 10K, 20K,40K, and80K tofind the optimized
cell-seeding density, which was experimentally determined to be
40K. This was followed by drug optimization tests, in which
the optimal final well concentrations were experimentally
determined to be 1 lmol/L for oligomycin, 1 lmol/L for
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP),
and 0.5 lmol/L of rotenone+0.5 lmol/L of antimycin A
(R+A). Mitochondria from L6 skeletal cells (p.9) were isolated
(from 100 cells per 1 recipient cell), using a commercially
available isolation kit (Thermo Fisher Scientific), and trans-
planted into H9c2 cardiomyocyte cells (p.10). Isolated
Clinical Perspective
What Is New?
• Our studies indicate that normal cellular bioenergetics is
acutely enhanced after mitochondrial transplantation.
• The current study delineates the potential of mitochondrial
transplantation for clinical application in settings where
there is an acute stress that would benefit from a boost in
cellular bioenergetics.
What Are the Clinical Implications?
• Given the observed bioenergetics profile of mitochondrial
transplantation in normal cells, a remaining question would
be if the post-transplantation bioenergetics profile will be
any different in cells with mitochondrial dysfunction.
• These studies are crucial in determining the possible
advantages of mitochondrial transplantation in mitigating
mitochondrial diseases, if any, as a cellular biotherapy.
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mitochondria were coincubated with H9c2 cells for 24 hours.
After that, anymitochondria not internalized intocardiomyocytes
were removed by changing the culture media. The Seahorse
assays were performed in Seahorse XF DMEM supplemented
with glucose to a final concentration of 10 mmol/L, sodium
pyruvate to 1 mmol/L, and L-glutamine to 2 mmol/L. Bioener-
getics measurements were performed, after sequential treat-
ment with Oligomycin, FCCP, and R+A (Agilent Technologies), at
2 (Figure 3), 7 (Figure 4), 14 (Figure 4), and 28 days (Figure 4)
post-transplantation and comparedwith that of the control group
to investigate the effect of mitochondrial transplantation in 2
sets of independent studies, with a total of 28 observations for
the experimental group and 12 for the control group. Raw data
were normalized to total protein using the Micro BCA Protein
Assay (Thermo Fisher Scientific).
Quantification of Mitochondrial Superoxide
Production
To assess the production of superoxide by mitochondria,
MitoSOX Red Mitochondrial Superoxide Indicator (Thermo
Fisher Scientific) was used. At 2 days post-transplantation,
Bioenergetics
Measurements and 
Analysis
28-day Post 
Transplant
Mitochondrial 
Superoxide 
Measurement
14-day Post 
Transplant
7-day Post 
Transplant
2-day Post 
Transplant
Microscopy
Time-Lapse
Confocal
Holotomography
Mitochondrial 
Isolation
Transplantation 
through co-incubation
Figure 1. Mitochondrial transplantation studies in a glance. Feasibility of mitochondrial transplantation (autologous, non-autologous,
and interspecies) was demonstrated using (A) wide-field time-lapse (Olympus, Tokyo, Japan) and (B) confocal (Zeiss Microscopy, Jena,
Germany) and (C) holotomography microscopy (Nanolive SA, Tolochenaz, Switzerland). Bioenergetics consequences of non-autologous
mitochondrial transplantation were studied using a Seahorse Extracellular Flux Analyzer (Agilent Technologies, Santa Clara, CA) (A) at 2,
(B) 7, (C) 14, and (D) 28 days post-transplantation. Mitochondrial superoxide was measured using MitoSOX Red Mitochondrial
Superoxide Indicator (Thermo Fisher Scientific, Waltham, MA).
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Figure 2. Internalization of mitochondria into H9c2 cardiomyocyte-like cells through coincubation. (A) Feasibility of mitochondrial
transplantation. The newly internalized mitochondria labeled with pHrodo Red Succinimidyl Ester (A.1.); the cell’s native mitochondria labeled
with MitoTracker Green FM (A.2.); the nucleus is labeled with NucBlue Live. The image was taken after 28 hours time-lapse using a structured
illumination epifluorescence microscope (Keyence, Itasca, IL). (B) Dynamics of mitochondrial internalization. Hour 5:00 represents the
cardiomyocytes before mitochondrial internalization. Media contains the fluorescently labeled mitochondria. Given that pHrodo Red SE fluoresces
brightly red only after it has been internalized by the cell, no florescence could yet be observed. At 5:05, the cardiomyocyte starts taking in the
mitochondria, as indicated by the red fluorescence signal (black arrow). As time passes, more mitochondria are internalized into the cell.
Moreover, there are interactions between the mitochondria, which are assumed to represent the dynamics of fusion and fission processes
(Olympus, Tokyo, Japan). (C) Non-autologous transplantation of mitochondria. Mitochondria from rat L6 skeletal muscle cell (shown in red) were
transplanted into H9c2 cardiomyocytes (Nanolive SA, Tolochenaz, Switzerland). (D) Interspecies transplantation of mitochondria. Mitochondria
from rat L6 skeletal muscle cells (shown in red) were transplanted into human ARPE-19 retinal epithelial cells. The cell’s native mitochondria are
shown in green, the transpalnted mitochondria in red, the nucleus in blue, and the plasma membrane, labeled with CellMask Deep Red Plasma
Membrane Stain, in yellow (Zeiss Microscopy, Jena, Germany).
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cells were incubated with MitoSOX Red (5 lmol/L) at 37°C for
10 minutes. Cells were then washed 3 times with sterile PBS.
Using a fluorescence plate reader, MitoSOX Red was excited at
485 nm and fluorescence emission was measured at 590 nm.
With 10 observations in each group, fluorescence values were
compared among the 2 groups of independent transplantation
experiments and a control group (Figure 5).
Statistical Analyses
An unpaired 2-tailed unequal variance t test (Welch’s test)
was used for the mean values of Seahorse bioenergetics
data in Microsoft Excel (Microsoft Corporation, Redmond,
WA). Welch’s test, which is a more-stringent test than the
Student t test, was used to account for: (1) the possibility of
mitochondrial transplantation changing the bioenergetics
both positively and negatively (2-tailed); (2) possible different
distributions of the control and transplant groups (unequal
variance), and that (3) the measurements were taken
independently (unpaired). To check for normality, qq plots
of the data were generated in R (R Foundation for Statistical
Computing, Vienna, Austria). Distribution in transplant
appeared to be, in fact, different from the control group.
Most observations fell within the 95% CI, and overall the
data were reasonably normally distributed. Results with
p<0.05 were considered as statistically significant. No
statistical methods were used to predetermine the sample
size. Sample size was based on experimental feasibility for
proof of concept. Graphs presented in Figures 3 through 6
were generated in Mathematica (Wolfram Research, Cham-
paign, IL). Data from bar graphs presented in Figures 3, 4,
and 6 are meansSEM, and data from kinetic profiles in
Figures 3 and 4 are meanSD from n=2 independent
experiments each with 14 biological replicates for the
experimental transplant group and 6 biological replicates
for the control group. For the 28-day post-transplantation
experiment, 27 observations were recorded versus the 28
for all the other time points, because of measurement failure
in one of the wells.
Welch’s test was used to compare post-transplant car-
diomyocytes’ mean superoxide production with that of the
control at the 5% level. Fluorescence values after MitoSOX
treatment were recorded from n=2 independent transplant
groups and compared with n=1 control group, each with 10
biological replicates. No statistical methods were used to
predetermine sample size. Fluorescence values are displayed
as box and whisker plots in Figure 5. Fluorescence measure-
ments from the mitoSOX-treated control and transplant
groups were normalized to the mean fluorescence measure-
ment value of the untreated control. Mitochondrial superoxide
production is reported as the normalized fluorescence
valuesSD and presented as bar graphs in Figure 5.
Results
Inspired by the endosymbiosis theory of mitochondrial origin,
we hypothesized and tested whether coincubation of isolated
mitochondria with cells would allow for mitochondria’s uptake
by the cell and enhanced cellular bioenergetics state. First, we
evaluated autologous mitochondrial transplantation of rat
cardiomyocyte H9c2 cells (ATCC). Based on a 28-hour time-
lapse study (Figures 2A and 2B), we observed mitochondrial
internalization at various time points and visualized the
dynamics of mitochondrial internalization in time, as shown in
C D
Figure 2. (continued).
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Video S1. Figure 2B shows representative images demon-
strating cellular uptake of pHrodo Red Succinimidyl Ester–
labeled mitochondria (black arrow). Cells remained viable for
the duration of the experiment whereas the internalized
mitochondria appeared to undergo fission and fusion dynam-
ics, based on propagation of the pHrodo Red signal to the
entire cell (Figure 2B). From a mechanistic perspective, in
labeling isolated mitochondria with pHrodo Red Succinimidyl
Ester, the succinimidyl ester group interacts with the amine
group on the mitochondria and forms a covalent amide bond.
Nevertheless, to ensure specificity of the detected signal
representing mitochondrial internalization, we performed a
set of control experiments with 4 groups in the absence of
exogenous mitochondria, as described in Table 1. Collectively,
our experiments showed that the pHrodo dye by itself could
not passively internalize, and consequently the pHrodo-
labeled autologous mitochondria actively internalized into
the cells.
Next, we tested whether cells would similarly uptake
non-autologous mitochondria (Figure 2C). Mitochondria iso-
lated from rat L6 skeletal muscle cells (ATCC) were internal-
ized by rat cardiomyocyte H9c2 cells. This set of experiments
shows that non-autologous mitochondrial transplantation
between the 2 rat cell lines is possible.
Figure 3. Non-autologous mitochondrial transplantation of L6 skeletal cells into H9c2 cardiomyocytes leads to enhanced
bioenergetics 2 days post-transplantation. Top: Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) kinetics
increased 2 days post-transplantation, indicating improved metabolism after mitochondrial transplantation. Bottom: Compared with
control (lavender), there was a statistically significant increase in ATP production, basal respiration, and non-mitochondrial respiration in
the transplant (purple) group. Maximal respiration and spare respiratory capacity were also enhanced, although not statistically
significantly. Coupling efficiency and proton leak remained unchanged. A Welch’s test was used, and results with p<0.05 were
considered as statistically significant (n=28 for transplant and n=12 for control). Abbreviations: Oligo, oligomycin; FCCP, carbonyl
cyanide-p-trifluoromethoxyphenyl hydrazone; R+A, rotenone and antimycin A; n.s., not significant.
DOI: 10.1161/JAHA.119.014501 Journal of the American Heart Association 6
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Lastly, we investigated interspecies mitochondrial trans-
plantation by using isolated mitochondria from rat L6 cells
and transplanted them into human ARPE-19 retinal cells
(ATCC; Figure 2D). Similar to the previous experiments,
mitochondria were successfully internalized into cells, and
the feasibility of mitochondrial transplantation from rat to
human cells was demonstrated.
We then hypothesized and tested whether internalization
of transplanted non-autologous mitochondria would lead to
enhanced bioenergetics, by conducting the Cell Mito Stress
Test using a Seahorse Extracellular Flux Analyzer (Agilent). We
measured the OCR, which represents the rate of oxidative
phosphorylation and ECAR, which denotes the summation of
acid (H+) produced from glycolysis and the tricarboxylic acid
(TCA) cycle (by CO2), when obtained through the Mito Stress
Test. Subsequently, we compared the results with the control
groups with no transplantation event. Baseline and post-
transplant rates were measured at 4 different time points:
after 2 days to measure acute effects (Figure 3); after 7 days;
after 14 days to check bioenergetic indices around mito-
chondria turnover; and finally after 28 days to check for
long-term effect (Figure 4).We observed an upward shift in OCR
Figure 4. Acute enhancement in bioenergetics after mitochondrial transplantation diminishes in the long term. Top: No significant
change in OCR and ECAR kinetics could be observed 7, 14, and 28 days post-transplantation. Bottom: No significant difference was
found between the transplant (lavender) and control (purple) groups in the long term. Whereas bioenergetics returned to baseline levels
in the long term, no negative consequences to cells’ bioenergetics were observed because of the intervention. A Welch’s test was used,
and results with p<0.05 were considered as statistically significant (n=28 for transplant and n=12 for control for t=7 days and 14 days;
n=27 for transplant (because of well-measurement failure in 1 well) and n=12 for control for t=28 days). Abbreviations: OCR, oxygen
consumption rate; ECAR, extracellular acidification rate; Oligo, oligomycin; FCCP, carbonyl cyanide-p-trifluoromethoxyphenyl hydrazone;
R+A, rotenone and antimycin A.
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kinetics 2 days post-mitochondrial transplantation compared
with baseline (Figures 3). Compared with the control, we
observed a statistically significant improvement in basal
respiration and ATP production 2 days post-transplantation
(p=0.031 and p=0.025, respectively; Figure 3). Maximal respi-
ration and spare respiratory capacity—the cell’s bioenergetics
reserve in meeting a situation of high demand or acute/chronic
stress—were also enhanced after 2 days, although not
statistically significantly (p=0.060 for maximal respiration and
p=0.080 for spare respiratory capacity; Figure 3). Coupling
efficiency was unchanged given that both transplanted and
native mitochondria were healthy (Figure 3).
Mitochondrial superoxide production was measured 2 days
post-transplantation using MitoSOX Red in control and
transplant groups, and no significant difference was observed
among the groups.
Discussion
H9c2 cells are phenotypically purely aerobic given that the
heart tissue has a high energy demand, which is more
efficiently met by aerobic respiration and oxidative phospho-
rylation. Increase in OCR kinetics 2 days post-transplantation
is indicative of improved bioenergetics, which is justified by
more oxidative phosphorylation attributed to increased mito-
chondrial content (Figure 3). Based on our bioenergetics
results, it appears that in normal cells, mitochondrial
Figure 5. Mitochondrial superoxide production. H9c2 cells were exposed to MitoSOX Red reagent 48
hours after mitochondrial transplantation to measure superoxide production. MitoSOX Red was excited at
485 nm, and fluorescence emission was measured at 590 nm. Whisker box plot shows distribution of
fluorescence readings for 10 measurements per group. No statistically significant difference was observed
in the population’s mean of the post-transplant groups vs control. Fluorescence measurements of MitoSOX-
treated groups were normalized to the untreated control and are displayed as bar graphs, for the
meanSD. Symbols: White line denotes the population median, “x” indicates the population mean, and
filled black dots represent outliers.
Figure 6. Effect of high passage number (aging) on mitochondrial function. Mitochondrial function was reduced with increasing
passage number. This is indicated by the decrease in ATP production and coupling efficiency—positive indicators of mitochondrial
function—and increase in proton leak— a negative indicator of mitochondrial function. An unpaired 2-tailed unequal variance t test was
used, and results with p<0.05 were considered as statistically significant (n=28 for p# 12, 14, and 17 and n=27 for p# 23 for transplant
and n=12 for p# 12, 14, 17, and 23 for control). Abbreviations: OCR, oxygen consumption rate; p#, passage number, n.s., not
significant.
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transplantation leads to acutely enhanced bioenergetics.
However, these initial effects seem to diminish over time
and return to that of the baseline control (Figure 4).
In addition to OCR, we evaluated the ECAR from the Mito
Stress Test (Figures 3 and 4). In many cell types, mitochon-
drial activity (TCA cycle) that leads to CO2 production is a
significant source of extracellular acidification.19 Given that, in
our observation, the ECAR significantly decreased after R+A
injection, we suppose that, in our samples, acidification was
generated through the TCA cycle. However, from the Mito
Stress Test, only qualitative interpretation of the changes in
ECAR data can be made for kinetics after injection of R+A. If
the ECAR significantly decreases (ie, low residual ECAR) in
response to R+A, we infer the ECAR (before the injection of
R+A) is primarily being generated by CO2 production from the
TCA cycle. If the ECAR remains constant and/or increases in
response to R+A, then the ECAR before R+A treatment is
primarily being generated by glycolysis.20 It is also important
to note that the exogenous pyruvate and glutamine supple-
mented in the media can be directly shunted into the TCA
cycle, which leads to CO2 production independent of the CO2
produced from the pyruvate generated from glucose through
glycolysis. Given that we observed a decrease in response to
R+A in both control and transplant groups, we infer that CO2
is primarily being generated by the TCA cycle in this cell type.
Another viewpoint indicates that in both control and trans-
plant groups, cells were burning through the exogenous
pyruvate and glutamate. However, on the contrary, we interpret
our ECAR data (Figures 3 and 4) such that the increase in ECAR
kinetics in transplant versus the control group (Figure 3) is
attributable to CO2 production from the increased TCA cycle in
the transplant group. Glycolytic rate assay can delineate the
sole contribution of glycolysis or CO2 to ECAR, which we did not
perform in the current experiments.
Previously, Finck and Kelly21 reported that the energetic
needs of the cell finely tune the mitochondrial abundance, and
too many or too few mitochondria may lead to pathology.
In their review of myocardial energy metabolism, they
associated myocardial diseases with perturbations of mito-
chondrial biogenesis. PGC-1a (peroxisome proliferator-acti-
vated receptor gamma coactivator 1-alpha) is a protein that
drives mitochondrial biogenesis in cardiomyocytes by acti-
vating nuclear respiratory factor 1, which, in turn, triggers
expression of activated mitochondria, leading to transcription
and replication of the mitochondrial genome. Mice lacking
PGC-1a present with signs of heart failure. Alternatively,
downregulation of PGC-1a in mice leads to hypertrophic
cardiomyopathy, whereas prolonged overexpression of PGC-
1a in mice leads to increased biogenesis activity and
mitochondrial ultrastructural abnormalities, which ultimately
leads to death from heart failure.21 Based on our observa-
tions, the enhanced bioenergetics state is temporary, which
may imply that either the cell’s mitochondrial content is
returned to physiological levels, or the overall mitochondrial
activities are reduced to reflect the cell’s bioenergetics
needs. Given that the spare respiratory capacity, which
measures the cell’s capacity in meeting a situation of high
energy demand, is not significantly changed in the trans-
plant versus the control, it is less likely that the overall
mitochondrial activities have dampened and more likely that
mitochondrial content has returned to physiological levels.
Our observation corroborates with the findings of Finck and
Kelly, and, accordingly, we hypothesize that a normal cell
clears any excess mitochondria, keeping mitochondrial
content at physiological levels, as the plausible mechanism
for the return of the bioenergetics indices to the baseline
levels in the long term. In the case of an adjustment of
mitochondrial content, it is yet unclear whether the newly
transplanted mitochondria are cleared from the cell or
whether transplanted mitochondria have been adopted by
the host and the total mitochondrial level regardless of the
recipient or donor status is reduced to bring the bioener-
getics levels back to the physiological state.
Moreover, the long-term bioenergetics profile suggests that
there are no negative bioenergetics consequences attributable
to mitochondrial transplantation, and that the intervention can
be considered safe for the cell. The question that remains to be
answered is whether or not cells with damaged mitochondria
would take advantage of the newly introduced mitochondria,
given that those cells could uptake and adopt the mitochondria
differently than a normal cell, which is already able to
efficiently meet its bioenergetics demands.
It is also important to note that non-mitochondrial
respiration—an index that measures oxygen consumed by
the cell by processes that are non-mitochondrial—signifi-
cantly increased after 2 days (p=0.033; Figure 3) and returned
to baseline after 7, 14, and 28 days (p>0.05 for all; Figure 4).
Non-mitochondrial respiration is neither well understood nor
well studied.22 Some non-mitochondrial processes that use
oxygen are superoxide production (with deleterious effects for
Table 1. Validation Experiment for Mitochondrial
Transplantation
Group Descriptions
1. pHrodo Red SE dye present in the media, with no cells plated
2. Cells in the absence of pHrodo Red SE dye in the media
3. Cells in the presence of pHrodo Red SE dye in the media
4. Cells in the presence of pHrodo Red SE dye in the media, and native
mitochondria fluorescently labeled with MitoTracker Green FM to
control for proper function of microscope and fluorescent signal
detection
pHrodo Red SE indicates pHrodo Red succinimidyl ester.
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mitochondria23,24) and hydrogen peroxide production.25 It is
known that hydrogen peroxide protects the cell from super-
oxide production given that it is properly degraded by
catalase; otherwise, it can break apart and form hydroxyl
radicals. The increase in non-mitochondrial respiration could
either suggest an improved overall metabolism or stress,
which needs to be further investigated.
In a normal, tightly coupled electron transport chain, 1%
to 3% of consumed oxygen is incompletely reduced, which can
lead to superoxide production as a result of the interaction
between leaky electrons and molecular oxygen.26,27 Given
that we had observed a statistically significant enhancement
in bioenergetics attributable to increased oxidative phospho-
rylation at 2 days post-transplantation, we used the mito-
chondrially targeted derivative of hydroethidine—MitoSOX
Red—to detect and quantitate the level of superoxides
produced by mitochondria in post-transplant and control
groups 2 days after transplantation. Compared with control,
no statistically significant difference was found in superoxide
production in the post-transplant group (p=0.99 and p=0.83
for set 1 and 2 transplantations, respectively; Figure 5). The
reported superoxide production was not assessed for the
same Seahorse experiment, but a representative one.
Finally, we observed a reduction in mitochondrial function
in the studied groups with increasing of the passage
number. ATP production and coupling efficiency, positive
indicators of bioenergetics, significantly decreased with
increasing passage number, whereas proton leak, a negative
indicator of bioenergetics, significantly increased (Figure 6).
This observation corroborates with the findings of a previous
study by Witek et al,28 where they observed an increase in
oxidative stress in cells with passaging of cardiomyocytes. It
appears that mitochondrial function is reduced in cells with
a higher passage number, and thus these cells are not
representative of the initial passages. The H9c2 cell line is a
well-established cell line used for assessing drug-induced
cardiotoxicity,28 and this observation indicates that only
lower passages of this line should be used to consider
mitochondrial adverse events.
Limitations
Given that the focus of the present study has been on
mitochondrial oxidative phosphorylation, the Mito Stress Test
was conducted. Thus, the ECAR kinetics presented in
Figures 3 and 4 represent the summation of acid (H+)
produced from glycolysis and CO2 produced from the TCA
cycle. Accordingly, the ECAR data in this study are not a direct
measurement of glycolysis. The XF Glycolytic Rate Assay
should be performed to quantitate the changes attributable to
glycolysis.
Conclusions
Our studies suggest that mitochondrial transplantation leads
to transiently enhanced bioenergetics in normal cardiomy-
ocytes, as evident by the statistically significant increase in
cells’ basal respiration and ATP production. In our long-term
post-transplantation studies, bioenergetics returned to phys-
iological levels in normal recipient cells, and more studies are
necessary to determine whether the outcome would be
different in recipient cells with dysfunctional mitochondria.
Although these enhancements were short-lived in normal
cells, it is evident that there were also no adverse effects
attributable to the transplantation, given that the transplant
cells were doing as well as the control cells in the long term,
and there was no increase in mitochondrial superoxide
production, which is a negative by-product of oxidative
phosphorylation.
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Supplemental Video Legend: 
 
Video S1. Dynamics of Mitochondrial Internalization. In this video clip, dynamics of 
mitochondrial internalization is visualized. The isolated mitochondria labeled with pHrodo 
Red Succinimidyl Ester (SE) are being internalized into the rat H9c2 cardiomyocytes through co-
incubation. The pHrodo Red SE label is sensitive to pH drop and fluoresces as endocytosed by 
the cell. The lack of fluorescence outside of the cell eliminates any doubt about the specificity of 
the detected signal. At around hour 5, the first instance of mitochondrial internalization is 
observed. The fluorescence intensity progressively decreases as the dye is segregated between 
the new daughter mitochondrion with each round of fission. Occasionally the fluorescence 
intensity increases locally, indicating new instances of mitochondrial internalization in those 
areas. With passing time, the pHrodo Red SE signal propagates through the entire cell, perhaps 
due to mitochondrial fission and fusion events between the transplanted and host mitochondria. 
The cell remains viable for the duration of the time-lapse study. Best viewed with Windows 
Media Player. 
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